We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.89T
1-Year Est. Return 35.08%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
-3.97%
1 Year Est. Return
+35.08%
3 Year Est. Return
+108.59%
5 Year Est. Return
+118.76%
10 Year Est. Return
+561.53%
AUM
$734B
AUM Growth
-$36.7B
Cap. Flow
+$3.56B
Cap. Flow %
0.48%
Top 10 Hldgs %
15.88%
Holding
8,241
New
197
Increased
3,111
Reduced
3,746
Closed
238

Sector Composition

Rank Sector Weight
1 Technology 17.71%
2 Healthcare 11.34%
3 Financials 9.38%
4 Consumer Discretionary 8.31%
5 Communication Services 5.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WFH
6451
DELISTED
Direxion Work From Home ETF
WFH
$25K ﹤0.01%
595
+350
+143% +$16.9K
WVVI icon
6452
Willamette Valley Vineyards
WVVI
$12M
$25K ﹤0.01%
4,076
+1
+0% +$6
WEL
6453
DELISTED
Integrated Wellness Acquisition Corp
WEL
$25K ﹤0.01%
2,510
BOAC.U
6454
DELISTED
Bluescape Opportunities Acquisition Corp. Units, each consisting of one Class A ordinary share, and one-half of one redeemable warrant
BOAC.U
$25K ﹤0.01%
2,530
CCV
6455
DELISTED
Churchill Capital Corp V
CCV
$25K ﹤0.01%
+2,500
New +$24.7K
ZYNE
6456
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$25K ﹤0.01%
34,989
-1,271
-4% -$1.44K
EBET
6457
DELISTED
EBET, INC. Common Stock
EBET
$25K ﹤0.01%
694
-1,126
-62% -$69.9K
EQOS
6458
DELISTED
EQONEX LIMITED Ordinary Shares
EQOS
$25K ﹤0.01%
63,312
CRHC
6459
DELISTED
Cohn Robbins Holdings Corp.
CRHC
$25K ﹤0.01%
2,519
-2,500
-50% -$24.2K
MACK
6460
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$25K ﹤0.01%
6,514
-844
-11% -$3.9K
ARC
6461
DELISTED
ARC Document Solutions, Inc.
ARC
$25K ﹤0.01%
11,236
+4,672
+71% +$13K
CMCT
6462
Creative Media & Community Trust
CMCT
$15M
-1
Closed -$171K
ELA icon
6463
Envela
ELA
$420M
$24K ﹤0.01%
4,849
-3,907
-45% -$27.7K
FCEF icon
6464
First Trust Exchange-Traded Fund VIII First Trust Income Opportunities ETF
FCEF
$82.6M
$24K ﹤0.01%
1,287
FFEB icon
6465
FT Vest US Equity Buffer ETF February
FFEB
$1.42B
$24K ﹤0.01%
721
GGR icon
6466
Gogoro
GGR
$44.6M
$24K ﹤0.01%
322
-1,740
-84% -$186K
CBIO
6467
Crescent Biopharma
CBIO
$618M
$24K ﹤0.01%
436
HEPS
6468
D-Market Electronic Services & Trading
HEPS
$1.01B
$24K ﹤0.01%
25,775
-109,485
-81% -$104K
LFMD icon
6469
LifeMD
LFMD
$167M
$24K ﹤0.01%
12,530
-10,830
-46% -$25.8K
MLTX icon
6470
MoonLake Immunotherapeutics
MLTX
$1.4B
$24K ﹤0.01%
+3,100
New +$21.9K
NXGL icon
6471
NexGel
NXGL
$4.51M
$24K ﹤0.01%
15,900
PAYS icon
6472
Paysign
PAYS
$735M
$24K ﹤0.01%
10,097
-4,021
-28% -$9.63K
RCG
6473
RENN Fund
RCG
$19.7M
$24K ﹤0.01%
11,000
-28,266
-72% -$62.8K
RPAR icon
6474
RPAR Risk Parity ETF
RPAR
$583M
$24K ﹤0.01%
1,400
SATL icon
6475
Satellogic
SATL
$906M
$24K ﹤0.01%
5,150
+5,000
+3,333% +$21.8K

Similar funds

Morgan Stanley's Q3 2022 Portfolio in Review

As of Q3 2022, Morgan Stanley held 8,241 positions worth $734B, down 4.8% from $770B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Morgan Stanley's Q3 2022 filing shows 197 new, 3,111 increased, 3,746 reduced and 238 closed positions. Its largest new stake was Mondee Holdings, Inc. Class A Common Stock: 9,699,165 shares worth $75.8M. The largest sale was Amgen, an estimated $568M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.

  • Morgan Stanley's largest Q3 2022 buy was Mondee Holdings, Inc. Class A Common Stock: 9,699,165 shares worth $75.8M.
  • Morgan Stanley added most to State Street SPDR S&P 500 ETF Trust in Q3 2022, an estimated $836M increase.
  • Morgan Stanley's biggest Q3 2022 reduction was Amgen, cutting an estimated $568M.
  • Morgan Stanley fully exited Coherent Inc in Q3 2022, selling an estimated $104M.
  • Morgan Stanley's ten largest holdings make up 16% of its $734B portfolio in Q3 2022.
  • Morgan Stanley opened 197 new positions and closed 238 in Q3 2022.
  • Morgan Stanley's portfolio value fell 4.8% quarter-over-quarter to $734B.

Based on Morgan Stanley's 13F filing for Q3 2022, filed 14 Nov 2022.